US diabetic macular edema cases projected to reach 0.5 million by 2031
Data on cases of diabetic macular edema (DME) in the seven major markets revealed that the US has the highest diagnosises, with forecasted cases expected to rise to 0.5 million by 2031.
Projections in GlobalData’s latest report showed that, among the seven major countries (US, Germany, Japan, UK, Spain, Italy, France), cases were said to increase from 1.7 million in 2021 to 2 million in 2031, with an annual growth rate of 1.66%.
Predictions for 2031 put Germany and UK as the next highest after the US, whereas France will have the lowest number at nearly 0.17 million cases.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here